![Patrice Sellès](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Patrice Sellès
Nessuna posizione attualmente
Provenienza dei contatti di primo grado di Patrice Sellès
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
15
| Public Company | Chemicals: Agricultural | 15 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Patrice Sellès tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
ABLYNX | Biotechnology | Director of Finance/CFO Director/Board Member | |
Vlerick Leuven Gent Management School | College/University | Masters Business Admin Masters Business Admin | |
Ghent University | College/University | Chief Operating Officer Doctorate Degree | |
ABIONYX PHARMA | Pharmaceuticals: Major | Director/Board Member | |
Creabilis SA | Director/Board Member | ||
OXFORD BIOMEDICA PLC | Biotechnology | Director/Board Member | |
Noema Pharma AG
![]() Noema Pharma AG BiotechnologyHealth Technology Noema Pharma AG is a biotechnology company, which engages in the development of orphan neurological disorder therapies. It focuses on understanding and meeting patient needs using novel therapies. The company was founded by Luigi Costa and George Garibaldi and is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member | |
DNA Script SAS
![]() DNA Script SAS Medical SpecialtiesHealth Technology DNA Script engages in the provision of research and development in biotechnology. It manufactures synthetic deoxyribonucleic acid using enzymatic technology. The company was founded by Thomas Ybert, Sylvain Gariel and Xavier Godron in 2014 and is headquartered in Paris, France. | Medical Specialties | Director/Board Member | |
Asceneuron SA
![]() Asceneuron SA Pharmaceuticals: MajorHealth Technology Asceneuron SA operates as a biotechnology company. It develops therapeutics for orphan tauopathis and Alzheimer?s disease. The firm specializes in small molecule drug discovery for neurodegenerative diseases. The company was founded by Dirk Beher, Frank Murdoch Armstrong and Christoph Wiessner in October 2012 and is headquartered in Lausanne, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
ZEALAND PHARMA A/S | Pharmaceuticals: Major | Director/Board Member | |
CMR Surgical Ltd.
![]() CMR Surgical Ltd. Medical SpecialtiesHealth Technology CMR Surgical Ltd. develops universal robotic system for minimal access surgery. The firm is presently evaluating the ability of the versius system to perform upper GI, gynaecological, colorectal and renal surgery in cadaveric trials. The company was founded by Martin Frost and Mark Slack in January 2014 and is headquartered in Cambridge, the United Kingdom. | Medical Specialties | Director/Board Member | |
Kymab Group Ltd.
![]() Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Kymab Group Ltd. is a British biopharmaceutical company that develops human monoclonal antibody drugs. The company is based in Cambridge, UK. The company was founded in 2016 by Alan Bradley. Kymab Group was acquired by Sanofi Foreign Participations BV on April 09, 2021 for $1,970.99 million. | Pharmaceuticals: Major | Director/Board Member | |
MOONLAKE IMMUNOTHERAPEUTICS | Pharmaceuticals: Major | Director/Board Member | |
IRONWOOD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
ORPHAZYME A/S | Pharmaceuticals: Major | Director/Board Member | |
Calliditas Therapeutics Suisse SA
![]() Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Pharmaceuticals: Generic | Director/Board Member | |
GENKYOTEX SA. | Pharmaceuticals: Major | Director/Board Member | |
MedDay Pharmaceuticals SAS
![]() MedDay Pharmaceuticals SAS BiotechnologyHealth Technology MedDay Pharmaceuticals SAS operates as a biotechnology company developing new drugs for nervous system disorders. The firm operates for the treatment of neuro-metabolic diseases. The company was founded by Frédéric Sedel and Guillaume Brion in 2011 and is headquartered in Paris, France. | Biotechnology | Chief Executive Officer | |
Kymab Ltd.
![]() Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
deVGen NV
![]() deVGen NV BiotechnologyHealth Technology deVGen NV provides biotechnology services for the pharmaceutical and agrochemical industries. It innovates in crop protection research and environment induced stress tolerance for its own crops and provides technology to corporate partners. The firm produces and sells its hybrid seeds in field crops such as rice, sunflower, sorghum and pearl millet in the Indian subcontinent and Southeast Asia. The company was founded by Thierry Bogaert on September 10, 1997 and is headquartered in Ghent, Belgium. | Biotechnology | Corporate Officer/Principal | |
Moonlake Immunotherapeutics AG
![]() Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Arnout Ploos van Amstel, Jorge Santos da Silva, Kristian Reich. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | Pharmaceuticals: Major | Director/Board Member | |
John Carroll University | College/University | Undergraduate Degree | |
Bayer CropScience NV
![]() Bayer CropScience NV Wholesale DistributorsDistribution Services Part of Bayer AG, Bayer CropScience NV is a Belgian company that wholesales fertilizers and other agrochemical products. The company is based in Diegem, Belgium. The company was founded in 1972. Sylvain Moissionnier has been the CEO of the company since 2020. | Wholesale Distributors | Corporate Officer/Principal | |
Syngenta Seeds NV
![]() Syngenta Seeds NV Agricultural Commodities/MillingProcess Industries Syngenta Seeds NV is a Belgian company that manufactures and supplies vegetable seeds and chemicals. The company is based in Ghent, Belgium. The company is ultimately controlled by the Government of China. The company was founded in 1949. The CEO is Martin van Gheluwe. | Agricultural Commodities/Milling | Corporate Officer/Principal | |
The Trustees of Columbia University in The City of New York | College/University | Corporate Officer/Principal | |
University of Leiden | College/University | Doctorate Degree | |
Commonwealth Scientific & Industrial Research Organisation
![]() Commonwealth Scientific & Industrial Research Organisation Miscellaneous Commercial ServicesCommercial Services Commonwealth Scientific & Industrial Research Organisation provides scientific and industrial research services. It plays a role in collaboration within the Australian national innovation system and as an advisor to government, industry and the community. The company was founded in 1916 and is headquartered in Canberra, Australia. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Sanofi Belgium NV
![]() Sanofi Belgium NV BiotechnologyHealth Technology Part of Sanofi, Sanofi Belgium NV is a Belgian company that produces and markets biological drugs. The company is based in Diegem, Belgium. The company was founded in 1998. The CEO is Johan Heylen. | Biotechnology | Corporate Officer/Principal | |
Katholieke Universiteit Leuven | College/University | Doctorate Degree | |
K+S Minerals & Agriculture GmbH
![]() K+S Minerals & Agriculture GmbH Chemicals: AgriculturalProcess Industries K+S Minerals & Agriculture GmbH operate as a mining company. It offers soil conditioners, as well as liquid and foliar fertilizers. The company is headquartered in Kassel, Germany. | Chemicals: Agricultural | Director/Board Member | |
BASF Corp.
![]() BASF Corp. Chemicals: Major DiversifiedProcess Industries BASF Corp. manufactures commercial and industrial chemicals. The firm serves the aerospace, agriculture, automotive, clean energy, nutrition, textiles, and building, and construction sectors. The company was founded in 1986 and is headquartered Florham Park, NJ. | Chemicals: Major Diversified | Corporate Officer/Principal | |
BASF SA
![]() BASF SA Chemicals: Major DiversifiedProcess Industries Part of BASF SE, BASF SA is a Brazilian company that manufactures chemicals, paints, agricultural products and others. The company is based in São Paulo, Brazil. | Chemicals: Major Diversified | Corporate Officer/Principal | |
BASF SE | Electrical Products | Corporate Officer/Principal | |
Shell International Ltd.
![]() Shell International Ltd. Miscellaneous Commercial ServicesCommercial Services Shell International Ltd. provides business support services. It engages in upstream and downstream oil and gas businesses in the United Kingdom and internationally. The company is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
K+S AG | Chemicals: Specialty | Director/Board Member | |
Universidad Argentina de la Empresa | College/University | Undergraduate Degree | |
Universidad del CEMA | College/University | Masters Business Admin | |
Université Libre de Bruxelles | College/University | Graduate Degree | |
MORGAN STANLEY | Investment Managers | Corporate Officer/Principal | |
University of Antwerp | College/University | Graduate Degree | |
University of British Columbia | College/University | Corporate Officer/Principal | |
The International Plant Nutrition Institute
![]() The International Plant Nutrition Institute Miscellaneous Commercial ServicesCommercial Services The International Plant Nutrition Institute (NPCT) is an American company that promotes the proper utilization of plant nutrients. NPCT is based in Piracicaba, Brazil, and has a team of experienced professionals who are dedicated to serving clients seeking the sustainability of agricultural systems with the use of good practices for nutrient management. The company offers a broad range of services, including lectures, online courses, and publications on topics related to crop nutrient management. The company also organizes and promote events related to soils and plant nutrition, such as symposiums and online courses. NPCT's mission is to optimize production under the technical-agronomic, economic, social, and environmental aspects of plant nutrient management. | Miscellaneous Commercial Services | Director/Board Member | |
University of Cambridge | College/University | Corporate Officer/Principal | |
NOVARTIS AG | Pharmaceuticals: Major | Director/Board Member | |
Government of Germany | Sovereign | President | |
University of Oxford | College/University | Doctorate Degree |
Statistiche
Distribuzione geografica
Belgio | 11 |
Regno Unito | 9 |
Stati Uniti | 8 |
Svizzera | 7 |
Francia | 5 |
Settori
Health Technology | 23 |
Consumer Services | 14 |
Process Industries | 7 |
Commercial Services | 4 |
Finance | 3 |
Posizioni
Director/Board Member | 33 |
Corporate Officer/Principal | 31 |
Independent Dir/Board Member | 17 |
Director of Finance/CFO | 7 |
Graduate Degree | 7 |
Contatti più connessi
Insiders | |
---|---|
Catherine Moukheibir | 29 |
Simon Moroney | 11 |
Luc Basstanie | 11 |
Kevin R. Helash | 10 |
Wim Ottevaere | 7 |
Markus Heldt | 7 |
Michiel van Lookeren Campagne | 6 |
Luc Maertens | 4 |
Diego Angelo | 3 |
Carlo Boutton | 3 |
Eva van Hende | 3 |
Patrick McDonnell | 2 |
Sophie Snijders | 2 |
Mike Stepan | 1 |
Douglas Minder | 1 |
- Borsa valori
- Insiders
- Patrice Sellès
- Connessioni Società